Trial intelligence / Profile preview

Bioavailability of nicorandil in healthy volunteers

2008-005532-32Phase 4Completed

Sponsor
Kwizda Pharma
Start
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of nicorandil in cardiac morbidity, sponsored by Kwizda Pharma. Primary endpoints: AUC0-tz, Cmax and 4 more. Started Oct 2008; status: completed.

02

Drugs

nicorandil
03

Conditions

cardiac morbidity

Beyond the preview

Go deeper on 2008-005532-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005532-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call